Stemodontics

What Stemodontics does

Stemodontics, LLC is a privately held, San Francisco-based dental pulp stem cell banking service that harvests, processes, and cryogenically stores mesenchymal stem cells extracted from the wisdom teeth of adolescents and young adults (ages 13-24). The company operates an FDA-registered, GMP-compliant laboratory and storage facility at 435 Pacific Avenue, executing a proprietary extraction protocol that it reports achieves a 98% success rate in producing viable preserved stem cells. Customers are individual families who enroll directly through the Stemodontics website or via a network of certified oral and maxillofacial surgeons who perform the wisdom-tooth extraction and follow company protocols for cell collection and shipping.

The commercial model combines a one-time processing fee of $699 with a recurring cryo-storage subscription of $12.95 per month, plus a retrieval service that ships banked cells to a customer's medical provider when needed for treatment. The go-to-market is direct-to-consumer supported by a certified provider channel, with top-of-funnel demand generated through a clinical research blog, social media presence on Instagram and Facebook, educational video content, and earned media coverage on regional TV networks.

Scientific and clinical credibility is anchored by a director/advisor bench of physician-scientists affiliated with Stanford (Dr. Michael T. Longaker, 1,200+ peer-reviewed publications), UCSF and Cedars-Sinai (Dr. Ophir Klein), Harvard School of Dental Medicine and Massachusetts General Hospital (Dr. Leonard B. Kaban), USC Keck (Dr. Mark Urata), and UTHealth Houston (Dr. Christopher Daniel). The company is structured as a California LLC with 11-50 employees, no disclosed institutional funding, and no parent company; the lab is reportedly fully booked for processing new cases until April 1, 2026, indicating demand currently exceeds throughput capacity.

Name

Stemodontics

Legal name

Stemodontics, LLC

Website

https://stemodontics.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Stemodontics is a San Francisco-based DTC service that extracts, processes, and cryo-stores stem cells from the wisdom teeth of children and young adults (ages 13-24) for potential future regenerative-medicine use, charging a $699 one-time fee plus $12.95/month storage.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industry

Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)

Keywords

• Stem cell banking
• Dental pulp stem cells
• Wisdom teeth storage
• Regenerative medicine services
• Cryogenic cell preservation

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Stem Cell Banking - Initial Processing: One-time processing fee covering extraction and expansion of stem cells from wisdom teeth. Includes initial enrollment and laboratory processing.
2. Stem Cell Banking - Monthly Storage: Recurring monthly fee for cryo-storage of preserved stem cells until withdrawal or service termination. Billed at $12.95/month.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Stemodontics operates a dental pulp stem cell banking service: it collects stem cells from wisdom teeth extracted by its network of certified oral and maxillofacial surgeons, processes and expands the cells at its FDA-registered GMP-compliant laboratory in San Francisco, and cryo-stores them for potential future regenerative medicine use. Customers enroll directly through the website and pay a $699 one-time processing fee plus $12.95/month for ongoing storage.

Product overview

Stemodontics offers a unified dental pulp stem cell banking service centered on the extraction, processing, expansion, and long-term cryo-storage of stem cells harvested from wisdom teeth. The core product encompasses the entire customer journey: collection kit provision to certified oral surgeons, stem cell extraction and expansion at their GMP-compliant California facility, and cryo-storage at $12.95/month with an initial processing fee of $699. The service includes a stem cell retrieval option for medical providers when cells are needed for treatment. The company maintains a network of Stemodontics-certified oral surgery providers and emphasizes a 98% success rate in viable stem cell recovery.

Differentiator

Problem solved

Functional benefit

Products and services

• Stem Cell Banking Service Dental pulp stem cell banking service that collects stem cells from extracted wisdom teeth, processes and expands them using GMP-compliant methods at the San Francisco laboratory, and cryo-stores them for potential future medical use in personalized regenerative medicine treatments. Customers enroll through the Stemodontics website.
• Stem Cell Retrieval Service Service for retrieving banked stem cell samples when needed for medical treatment, coordinating shipping directly to the customer's medical provider.

Quantifiable outcome

• 98% success rate in stem cell extraction and preservation protocol

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• Stanford Institute for Stem Cell Biology & Regenerative MedicinecoreStrategic or Co-development PartnerDr. Michael T. Longaker serves as co-director of the Stanford Institute for Stem Cell Biology & Regenerative Medicine. He has dedicated years of research to tissue repair, replacement, and regeneration harnessing stem cells, leading to more than 1,200 peer-reviewed publications.
• Cedars-Sinai Guerin Children'scoreStrategic or Co-development PartnerDr. Ophir Klein serves as the inaugural executive director of Cedars-Sinai Guerin Children's and holds the David and Meredith Kaplan Distinguished Chair in Children's Health.
• Harvard School of Dental Medicine / Massachusetts General HospitalcoreStrategic or Co-development PartnerDr. Leonard B. Kaban served as Chairman of the Department of OMFS at Harvard School of Dental Medicine and Chief of the OMFS Service at Massachusetts General Hospital from 1994 through 2015.
• University of California, San Francisco (UCSF)coreStrategic or Co-development PartnerDr. Ophir Klein previously served as Director of the Institute for Human Genetics, Chief of the Division of Medical Genetics, and Director of the Program in Craniofacial Biology at UCSF.
• University of Texas Health Science Center at Houston School of DentistrycoreStrategic or Co-development PartnerDr. Christopher Daniel serves as Assistant Professor, Director of Undergraduate OMFS Education, and holds the Nguyen-Thang Family Professorship in OMFS at UTHealth School of Dentistry.
• Keck School of Medicine of USC / USC School of DentistrycoreStrategic or Co-development PartnerDr. Mark Urata holds faculty appointments at both the Keck School of Medicine of USC and the USC School of Dentistry.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• StemSave: StemSave is a direct competitor offering dental stem cell banking from extracted teeth (including wisdom teeth). Like Stemodontics, it serves consumers through a network of dentists and oral surgeons and uses cryogenic storage, making it the closest one-to-one comparable.
• Store-A-Tooth: Store-A-Tooth provides dental stem cell preservation services from teeth (including wisdom teeth) sent through participating dentists. It directly overlaps Stemodontics' core offering, target demographic, and direct-to-consumer-plus-dentist-channel model.
• BioEden: BioEden offers stem cell banking from children's teeth (particularly baby teeth and wisdom teeth) via a network of dentists. It is a direct peer in dental pulp stem cell banking, though it has historically focused on the UK/European market.

Broad incumbents

• Cryo-Cell International: Cryo-Cell is an established public stem cell bank primarily focused on cord blood and menstrual blood banking. It is a broader incumbent in the consumer stem cell banking category that competes for family healthcare dollars with overlapping recurring-revenue storage economics.
• ViaCord: ViaCord (a Revvity company) is a major cord blood and cord tissue banking service targeting expectant parents. It competes for the same family-health-aspiration spend as Stemodontics and shares the recurring storage revenue model, though its tissue source is different.
• Cord Blood Registry (CBR): CBR is one of the largest newborn stem cell banks in the US, specializing in cord blood and cord tissue storage. While focused on a different tissue source, it directly competes for parents seeking to preserve biological materials for their children's future medical use.

Regional players

• Future Health Biobank: Future Health Biobank is a UK/Europe-based stem cell bank offering cord blood, cord tissue, and dental pulp storage. It overlaps with Stemodontics on the dental pulp stem cell category and shares recurring-storage economics, but its primary geographic footprint is outside the US.
• Cell Care: Cell Care is an Australia-based cord blood and tissue bank. While it does not currently focus on dental pulp, it operates in the family stem cell banking category with comparable subscription storage economics and could expand into dental tissue banking competitively with Stemodontics.

Emerging players

• StemGenex: StemGenex is an emerging player in the adult stem cell therapy market, focused on autologous adipose-derived stem cell treatments. While not a direct banking competitor, it operates in the broader consumer stem cell category that surrounds Stemodontics' downstream therapeutic opportunity.

Others

• Cytori Therapeutics: Cytori (now closed/legacy) developed cell therapy technologies using adipose-derived regenerative cells. As an adjacent cell-processing and regenerative medicine infrastructure player, it provides context for the downstream therapeutic ecosystem that Stemodontics' banked samples may eventually serve.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/stemodonticsinc
• Instagraminstagram.com/stemodontics
• Xx.com/stemodontics
• LinkedInlinkedin.com/company/stemodontics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stemodontics